Diazyme Laboratories uses its proprietary enzyme technologies to develop diagnostic reagents which can be used on most automated chemistry analyzers in user-friendly formats. Diazyme’s products include test kits for diagnosis of cardiovascular disease, liver disease, cancer markers, renal disease, diabetes, and electrolytes.

Diazyme, an affiliate of General Atomics, is located in Poway, California and is a cGMP and ISO 13485 certified medical device manufacturer.

The establishment of the FemtoQuant™ technology allows Diayzme to convert numerous current heterogeneous immunoassays into homogenous enzymatic assays. These homogenous enzymatic assays are run on general clinical chemistry analyzers that are used in clinical laboratories. The 3 platform technologies essentially cover the sensitivities needed for the majority of clinical diagnostic tests including; metabolites, special proteins, drugs, hormones, vitamins and electrolytes.

View the Diazyme product range here.

 

Diazyme Laboratories Sales Enquiries

Call Banksia on 1300 769 944, +617 3902 3000, email or complete the below form.